BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33962608)

  • 1. Streptococcus salivarius inhibits immune activation by periodontal disease pathogens.
    MacDonald KW; Chanyi RM; Macklaim JM; Cadieux PA; Reid G; Burton JP
    BMC Oral Health; 2021 May; 21(1):245. PubMed ID: 33962608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Probiotics, Streptococcus salivarius K12 and M18, Suppress the Release of Volatile Sulfur Compounds and a Virulent Protease from Oral Bacteria: An In-Vitro Study.
    Park JA; Lee GR; Lee JY; Jin BH
    Oral Health Prev Dent; 2023 Aug; 21():259-270. PubMed ID: 37724895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A concerted probiotic activity to inhibit periodontitis-associated bacteria.
    Jansen PM; Abdelbary MMH; Conrads G
    PLoS One; 2021; 16(3):e0248308. PubMed ID: 33667279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro.
    Yoo HJ; Jwa SK; Kim DH; Ji YJ
    Clin Exp Dent Res; 2020 Apr; 6(2):207-214. PubMed ID: 32250565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lyophilized cell-free supernatants of the oral probiotics Streptococcus salivarius M18 and Streptococcus salivarius K12 show promises for milk safety.
    Karaçam S; Tunçer S
    Lett Appl Microbiol; 2023 Jan; 76(1):. PubMed ID: 36688767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of red wine and oenological extracts against periodontal pathogens in a validated oral biofilm model.
    Sánchez MC; Ribeiro-Vidal H; Esteban-Fernández A; Bartolomé B; Figuero E; Moreno-Arribas MV; Sanz M; Herrera D
    BMC Complement Altern Med; 2019 Jun; 19(1):145. PubMed ID: 31226983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coaggregation of Streptococcus salivarius with periodontopathogens: evidence for involvement of fimbriae in the interaction with Prevotella intermedia.
    Lévesque C; Lamothe J; Frenette M
    Oral Microbiol Immunol; 2003 Oct; 18(5):333-7. PubMed ID: 12930529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Systemic Immune Response to Ingestion of the Oral Probiotic Streptococcus salivarius BLIS K12.
    Laws GL; Hale JDF; Kemp RA
    Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1521-1529. PubMed ID: 34282568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro beneficial effects of Streptococcus dentisani as potential oral probiotic for periodontal diseases.
    Esteban-Fernández A; Ferrer MD; Zorraquín-Peña I; López-López A; Moreno-Arribas MV; Mira A
    J Periodontol; 2019 Nov; 90(11):1346-1355. PubMed ID: 31111495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coinfection with Fusobacterium nucleatum can enhance the attachment and invasion of Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans to human gingival epithelial cells.
    Li Y; Guo H; Wang X; Lu Y; Yang C; Yang P
    Arch Oral Biol; 2015 Sep; 60(9):1387-93. PubMed ID: 26143497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-Strain Probiotic Supplementation with a Product Containing Human-Native
    Cernioglo K; Kalanetra KM; Meier A; Lewis ZT; Underwood MA; Mills DA; Smilowitz JT
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959944
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial effect of probiotic bacteriocins on
    Reichardt E; Shyp V; Alig L; Verna C; Kulik EM; Bornstein MM
    J Oral Microbiol; 2024; 16(1):2304971. PubMed ID: 38288293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a bacteriocin-producing
    Lawrence GW; McCarthy N; Walsh CJ; Kunyoshi TM; Lawton EM; O'Connor PM; Begley M; Cotter PD; Guinane CM
    Gut Microbes; 2022; 14(1):2100203. PubMed ID: 35877697
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Begić G; Badovinac IJ; Karleuša L; Kralik K; Cvijanovic Peloza O; Kuiš D; Gobin I
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon Gamma Response in Human Saliva Following Exposure to the Oral Probiotic Streptococcus salivarius BLIS K12.
    Laws GA; Harold LK; Tagg JR; Hale JDF
    Probiotics Antimicrob Proteins; 2024 Feb; 16(1):93-98. PubMed ID: 36477439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of viable and heat-killed probiotic strains against oral pathogens.
    Chen YT; Hsieh PS; Ho HH; Hsieh SH; Kuo YW; Yang SF; Lin CW
    Lett Appl Microbiol; 2020 Apr; 70(4):310-317. PubMed ID: 31955445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review.
    Zupancic K; Kriksic V; Kovacevic I; Kovacevic D
    Probiotics Antimicrob Proteins; 2017 Jun; 9(2):102-110. PubMed ID: 28236205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Streptococcus salivarius K12 on Nasopharyngeal and Saliva Microbiome: A Randomized Controlled Trial.
    Sarlin S; Tejesvi MV; Turunen J; Vänni P; Pokka T; Renko M; Tapiainen T
    Pediatr Infect Dis J; 2021 May; 40(5):394-402. PubMed ID: 33298762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1alpha stimulation in monocytes by periodontal bacteria: antagonistic effects of Porphyromonas gingivalis.
    Bostanci N; Allaker R; Johansson U; Rangarajan M; Curtis MA; Hughes FJ; McKay IJ
    Oral Microbiol Immunol; 2007 Feb; 22(1):52-60. PubMed ID: 17241171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety assessment of
    Hale JDF; Jain R; Wescombe PA; Burton JP; Simon RR; Tagg JR
    Benef Microbes; 2022 Feb; 13(1):47-60. PubMed ID: 35098909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.